Related Experiment Video
Updated: Jul 13, 2026
07:15
A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing (Neo)adjuvant Therapies
Published on: July 28, 2020
A review of soft tissue sarcoma
1Division of Plastic and Reconstructive Surgery, University of Ilorin Teaching Hospital, Ilorin. ismailaadigun@yahoo.com
Summary
Soft tissue sarcomas (STS) management has advanced with imaging and adjuvant therapies. Multidisciplinary care is crucial for optimal treatment outcomes in these rare cancers.
Area of Science:
- Oncology
- Surgical Pathology
Background:
- Soft tissue sarcomas (STS) are rare, heterogeneous malignancies originating from embryonic mesoderm.
- They often present as asymptomatic masses, typically in extremities, but can occur elsewhere.
- STS constitute approximately 0.7% of all adult cancers.
Purpose of the Study:
- To review the current management approaches for soft tissue sarcomas.
- To highlight advancements in diagnostic and therapeutic strategies for STS.
Main Methods:
- Literature review focusing on soft tissue sarcoma management.
- Emphasis on diagnostic procedures and treatment modalities.
Main Results:
- Tru-cut biopsy is a safe and effective diagnostic tool for STS.
- Advanced imaging (CT, MRI, MRA) aids in tumor delineation.
- Limb-sparing surgery is now feasible for over 90% of extremity STS cases.
- Adjuvant radiotherapy and chemotherapy improve survival rates for high-grade and large sarcomas.
Conclusions:
- Optimal STS treatment necessitates a multidisciplinary approach.
- Collaboration among various medical specialists is key to achieving the best patient outcomes.
